Marlene Busko July 05, 2023 SAN DIEGO – In the largest randomized controlled trial of an automated insulin delivery (AID) system (hybrid closed-loop) versus standard insulin delivery in pregnant women with type 1 diabetes, the automated CamAPS FX system prevailed. The percentage of time spent in the pregnancy-specific target blood glucose range of 63-140 mg/dL...
Tag: <span>artificial pancreas</span>
Post
Artificial pancreas successfully trialed for use by type 2 diabetes patients
by University of Cambridge Credit: Pixabay/CC0 Public Domain Cambridge scientists have successfully trialed an artificial pancreas for use by patients living with type 2 diabetes. The device—powered by an algorithm developed at the University of Cambridge—doubled the amount of time patients were in the target range for glucose compared to standard treatment and halved the time...
Post
Artificial pancreas proves ‘life-changing’ for very young children with type 1 diabetes and their families
by University of Cambridge Credit: CC0 Public Domain An artificial pancreas developed by a team of Cambridge researchers is helping protect very young children with type 1 diabetes at a particularly vulnerable time of their lives. A study published today found that it is both safe to use and more effective at managing their blood...
Post
Artificial pancreas trialled for outpatients with type 2 diabetes for first time
UNIVERSITY OF CAMBRIDGE An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis. Tests led by the University of Cambridge and Inselspital, University Hospital of Bern, Switzerland, show that the device can help patients safely and effectively manage their blood sugar levels and reduce the risk of...
Post
‘Artificial Pancreas Dashboard’ to standardize hybrid closed-loop reporting
MARY ANN LIEBERT, INC./GENETIC ENGINEERING NEWS IMAGE: COVERS NEW TECHNOLOGY AND NEW PRODUCTS FOR THE TREATMENT, MONITORING, DIAGNOSIS, AND PREVENTION OF DIABETES AND ITS COMPLICATIONS. CREDIT: MARY ANN LIEBERT, INC., PUBLISHERS New Rochelle, NY, November 30, 2020–A standardized “Artificial Pancreas (AP) Dashboard” should provide easy to use single-page hybrid closed-loop system (HCL) reporting for insulin...
Post
FDA approves UVA-developed artificial pancreas
by University of Virginia Health System The U.S. Food and Drug Administration has approved an artificial pancreas system—based on technology from the University of Virginia Center for Diabetes Technology—that automatically monitors and regulates blood glucose levels. “We are excited that our decade-long research, which recently culminated in a large-scale clinical trial published in the New...